Acessibilidade / Reportar erro

"Syndromic surveillance" and the reemergence of yellow fever in São Paulo State, Brazil, 2009

LETTER TO THE EDITOR

"Syndromic surveillance" and the reemergence of yellow fever in São Paulo State, Brazil, 2009

Fortaleza CMCBI, II; Rocha RI; Aragão VDNI, II; Almeida RAMBI

IDepartment of Tropical Diseases and Imaging Diagnosis, Botucatu Medical School, São Paulo State University, UNESP, Botucatu, São Paulo State, Brazil

IIBauru State Hospital, Botucatu Medical School, São Paulo State University, UNESP, Botucatu, São Paulo State, Brazil

Correspondence to Correspondence to: Carlos Magno Castelo Branco Fortaleza Departamento de Doenças Tropicais e Diagnóstico por Imagem Faculdade de Medicina de Botucatu, UNESP, Distrito de Rubião Júnior, s/n Botucatu, SP, 18618-000, Brasil Phone: +55 14 3811 6212. Fax: +55 14 3815 9898 Email: cmfortaleza@uol.com.br.

Dear Editor:

Urban cases of yellow fever (YF) have not occured in Brazil since 1942. However, an annually variable number of sylvatic YF cases are reported to the health surveillance system (1). Traditionally, there was an extensive area in Brazil that was termed "endemic" for sylvatic YF. It included all the states in the north (Amazonia) and middle-west regions. Since the late 1990s, that area has been continuously expanding to the south and east, reaching more populated states. This is a matter of concern, since YF vaccine is currently not included in the immunization schedule for children living outside the "endemic" area.

The last two years have witnessed a substantial increase in the sensitivity of YF surveillance (2). This was partly due to active surveillance of epizootic events among non-human primates, a phenomenon that usually precedes the occurrence of human YF (3). However, the registration of human cases still relies mostly on traditional forms and strict case definition. A suspected case is defined as "an acute febrile disease accompanied by jaundice and hemorrhagic manifestations in a person who lives in or has traveled to an affected area and who was not vaccinated against YF in the last ten years". Clearly, this definition does not work for the initial cases in a recently affected area. Also, it does not detect non-icteric and/or non-hemorrhagic patients, a situation that probably accounts for the great majority of cases.

"Syndromic surveillance" is a method, proposed by the US Centers for Disease Control and Prevention (CDC, Atlanta) for early and enhanced detection of emerging infectious diseases (4). It relies on the identification of a set of signs and symptoms (a syndrome) from many sources (e.g., medical charts) and the application of a broad diagnosis approach. We aim to demonstrate how a hospital-based syndromic approach allowed early identification of YF cases in São Paulo state and the implementation of control measures (a vaccination campaign) in a timely fashion.

In 2005, the Brazilian Ministry of Health instituted a network of epidemiological surveillance offices in tertiary hospitals throughout the country. All participating hospitals were asked to develop alternative approaches to increase the sensitivity of their surveillance systems. Two teaching hospitals of the Botucatu Medical School (in Botucatu and Bauru cities, São Paulo state) chose to implement a surveillance of acute febrile ictero-hemorrhagic syndrome (AFIHS). The rationale of the surveillance was to avoid missing cases of hemorrhagic fevers, like leptospirosis and Brazilian spotted fever (BSF). Both diagnostic and therapeutic measures against AFIHS followed a syndromic approach, which indicates that all patients should be tested serologically for dengue, YF, BSF and leptospirosis. Additionally, blood cultures were performed to exclude sepsis of unknown origin.

On February 28th 2008, a woman from Sarutaiá (a city 70 km away from Botucatu) was admitted to the Bauru State Hospital (one of the teaching hospitals) with fever and jaundice. Laboratory tests revealed elevated liver enzymes and altered coagulation. The initial diagnostic hypothesis was leptospirosis. Still, the AFIHS approach was employed. Despite life-support measures, the woman developed massive hemorrhage of the respiratory tract and died within two days of admission. YF was serologically confirmed postmortem. On March 13th, a man from Itatinga (another city near Botucatu) was admitted to the Clinical Hospital of Botucatu Medical School with a hypothesis of fulminant viral hepatitis. He presented signs and symptoms similar to those of the first case, so that the AFIHS approach was also employed. YF was confirmed soon after his death. A summary of all other AFIHS cases, admitted to either of the teaching hospitals, is shown in Table 1.

One should note that the first two cases would have had their diagnosis delayed (or even missed) without AFIHS syndromic surveillance. All subsequent hypotheses of YF were based on the knowledge of those experiences. Moreover, active examination of symptomatic individuals in the cities where the first cases occurred permitted the finding of new cases. A total of 22 persons from four municipalities, in the Botucatu region, had YF diagnosed. There was a rapid response from the São Paulo State Health Surveillance Office, with an extensive vaccination campaign initiated on March 21st. More than 92% of the 509,000 inhabitants from 29 municipalities in the Botucatu region were vaccinated. No new cases have been registered in the region since the campaign. However, three YF cases were diagnosed in another region of São Paulo state in April 2009 (5).

Our point is that hospital-based syndromic surveillance aided in the timely implementation of control measures and prevented new cases and deaths. Perhaps the surveillance of other syndromes, like encephalitis and acute respiratory illnesses, could further improve our detection of emerging and reemerging diseases.

Received: May 5, 2009

Accepted: May 5, 2009

Full paper published online: May 30, 2009

  • 1. World Health Organization. Yellow fever in Africa and South America, 2007. Wkly Epidemiol Rec. 2009;84(13):97-104.
  • 2. World Health Organization. Outbreak news. Yellow fever, Brazil. Wkly Epidemiol Rec. 2008;83(7):61-2.
  • 3
    Brasil. Secretaria de Vigilância em Saúde. Mortes de macacos e a prevenção da febre amarela no Brasil, 2007 e 2008. Brasil, 2009. Available from: portal.saude.gov/portal/arquivos/pdf/nota_tecnica_epizootias_macasos_jan_2008_v2.pdf
  • 4
    Centers for Disease Control and Prevention. Syndromic surveillance. Reports from a national conference, 2004. MMWR Morb Mortal Wkly Rep. 2005;54(suppl):1-208.
  • 5
    5. São Paulo. Centro de Vigilância Epidemiológica. Febre amarela silvestre, Estado de São Paulo. Boletim de atualização – encerrado às 12h do dia 24.4.2009. São Paulo State, 2009. Available from: ftp.cve.saude.sp.gov.br/doc_tec/ZOO/Boletim_FASP_240409.pdf.
  • Correspondence to:

    Carlos Magno Castelo Branco Fortaleza
    Departamento de Doenças Tropicais e Diagnóstico por Imagem
    Faculdade de Medicina de Botucatu, UNESP, Distrito de Rubião Júnior, s/n
    Botucatu, SP, 18618-000, Brasil
    Phone: +55 14 3811 6212. Fax: +55 14 3815 9898
    Email:
  • Publication Dates

    • Publication in this collection
      09 June 2009
    • Date of issue
      2009
    Centro de Estudos de Venenos e Animais Peçonhentos (CEVAP/UNESP) Av. Universitária, 3780, Fazenda Lageado, Botucatu, SP, CEP 18610-034, Brasil, Tel.: +55 14 3880-7693 - Botucatu - SP - Brazil
    E-mail: editorial.jvatitd@unesp.br